ArticleMolecular cancer2013

miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.

Manuela Ferracin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.